AAIC 2018: Day 4 Update
Not able to attend AAIC this year? You can catch up with all the action from today with our daily video, best of social media and the biggest headlines.
Browsing: dementia
AAIC 2018: Could intensive blood pressure control reduce the risk of MCI and dementia?
Results from AAIC have revealed significant reductions in the risk of MCI and the combination of MCI and dementia through lowering systolic blood pressure.
AAIC 2018: Day 3 Update
Today was the third day of AAIC, with more fascinating talks and exciting posters. You can catch up on our daily update here with a focus on early careers.
AAIC 2018: Could the gut–liver–brain axis control Alzheimer’s risk?
Researchers at AAIC have reported new data on how the gut microbiome and lipid metabolism may influence Alzheimer’s and other brain diseases.
AAIC 2018: Treating non-cognitive symptoms of individuals with dementia
Research presented at AAIC 2018 highlights the challenges and successes of both drug and non-drug treatments for non-cognitive symptoms experienced by individuals with Alzheimer’s disease.
AAIC 2018: Day 2 Update
Today was the second day of AAIC, with more fascinating talks and exciting posters. You can catch up on the highlights, as well as the latest headlines and the best of social media in our daily update.
AAIC 2018: New National Strategy for recruitment and participation in Alzheimer’s disease trials
Research presented at AAIC reveals the development of the National Strategy and how community based outreach increases participation in Alzheimer’s research.
AAIC 2018: Pregnancy and reproductive history may impact dementia risk
Research presented at AAIC has highlighted sex differences associated with dementia and Alzheimer’s disease across the life course, including the first ever large-scale study of reproductive history and dementia risk in women.
AAIC 2018: Dementia prevalence in the LGBT community highlights need for outreach
The first data set regarding the prevalence of dementia in LGBT older adults has been announced, highlighting the need for further research and outreach.
FENS 2018: Epigenetic target identified in early treatment of Alzheimer’s disease
Researchers may be able to diagnose and treat Alzheimer’s disease before it becomes symptomatic, through a dietary drug which could be more effective than current treatments.
